组织陈列-产品详情

home > TISSUE ARRAYS > Baldder > UBD1002a

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

100

CASES:

50

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

10

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

UBD1002a

$255.00

Add To Collect

Description: Bladder cancer array with cancer adjacent tissue, including TNM and pathology grade, 50 cases/100 cores

Details: Bladder carcinoma microarray with cancer adjacent tissue, containing 40 cases of carcinoma (35 urothelial carcinoma, 4 squamous cell carcinoma, 1 adenocarcinoma), 10 cancer adjacent bladder tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

AT(*)
Malignant(I)
Malignant(II)
Malignant(IIIA)
Malignant(IIIB)
_ma

TISSUE ARRAYS
UBD1002a

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

UBD1002a

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Tumor size
A1	1	72	M	Bladder	Low-grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	432
A2	2	51	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	642
A3	3	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	43.53.5
A4	4	79	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5
A5	5	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	321.5
A6	6	72	M	Bladder	Low-grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	432
A7	7	51	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	642
A8	8	59	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	43.53.5
A9	9	79	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	1051.5
A10	10	45	F	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	321.5
B1	11	77	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
B2	12	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	552.5
B3	13	42	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	433
B4	14	71	M	Bladder	Low-grade urothelial carcinoma	*	T2bN0M0	II	Malignant	4.532
B5	15	50	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	532
B6	16	77	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
B7	17	72	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	552.5
B8	18	42	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	433
B9	19	71	M	Bladder	Low-grade urothelial carcinoma	*	T2bN0M0	II	Malignant	4.532
B10	20	50	M	Bladder	Low-grade urothelial carcinoma	*	T1N0M0	I	Malignant	532
C1	21	38	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	1083
C2	22	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
C3	23	73	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
C4	24	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	8*7
C5	25	45	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	1077
C6	26	38	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	1083
C7	27	48	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
C8	28	73	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
C9	29	71	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	8*7
C10	30	45	F	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	1077
D1	31	52	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	652
D2	32	69	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	2.52.52.5
D3	33	60	M	Bladder	High grade urothelial carcinoma	*	T3aN0M0	IIIA	Malignant	322
D4	34	35	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*
D5	35	65	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	331
D6	36	52	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	652
D7	37	69	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	2.52.52.5
D8	38	60	M	Bladder	High grade urothelial carcinoma	*	T3aN0M0	IIIA	Malignant	322
D9	39	35	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	*
D10	40	65	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	331
E1	41	70	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	653
E2	42	44	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E3	43	70	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
E4	44	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
E5	45	72	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
E6	46	70	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	653
E7	47	44	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	*
E8	48	70	M	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	543
E9	49	42	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321
E10	50	72	M	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
F1	51	67	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	433
F2	52	56	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
F3	53	53	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	542
F4	54	33	M	Bladder	High grade urothelial carcinoma	*	T3N1M0	IIIA	Malignant	*
F5	55	65	F	Bladder	High grade urothelial carcinoma	*	T3aN0M0	IIIA	Malignant	432
F6	56	67	M	Bladder	High grade urothelial carcinoma	*	T2aN0M0	II	Malignant	433
F7	57	56	M	Bladder	High grade urothelial carcinoma	*	T3N0M0	IIIA	Malignant	*
F8	58	53	M	Bladder	High grade urothelial carcinoma	*	T3bN0M0	IIIA	Malignant	542
F9	59	33	M	Bladder	High grade urothelial carcinoma	*	T3N1M0	IIIA	Malignant	*
F10	60	65	F	Bladder	High grade urothelial carcinoma	*	T3aN0M0	IIIA	Malignant	432
G1	61	37	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
G2	62	45	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
G3	63	55	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321.5
G4	64	25	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	13108
G5	65	70	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
G6	66	37	F	Bladder	High grade urothelial carcinoma	*	T2bN0M0	II	Malignant	*
G7	67	45	F	Bladder	High grade urothelial carcinoma	*	T1N0M0	I	Malignant	*
G8	68	55	M	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	321.5
G9	69	25	F	Bladder	Low-grade urothelial carcinoma	*	T2N0M0	II	Malignant	13108
G10	70	70	F	Bladder	High grade urothelial carcinoma	*	T2N0M0	II	Malignant	322
H1	71	46	M	Bladder	Squamous cell carcinoma	*	T2aN0M0	II	Malignant	*
H2	72	53	M	Bladder	Squamous cell carcinoma	*	T2N0M0	II	Malignant	4.54.53
H3	73	67	M	Bladder	Squamous cell carcinoma	*	T3aN0M0	IIIA	Malignant	443.5
H4	74	57	M	Bladder	Squamous cell carcinoma	*	T3aN0M0	IIIA	Malignant	*
H5	75	46	F	Bladder	Adenocarcinoma	*	T3bN2M0	IIIB	Malignant	*
H6	76	46	M	Bladder	Squamous cell carcinoma	*	T2aN0M0	II	Malignant	*
H7	77	53	M	Bladder	Squamous cell carcinoma	*	T2N0M0	II	Malignant	4.54.53
H8	78	67	M	Bladder	Squamous cell carcinoma	*	T3aN0M0	IIIA	Malignant	443.5
H9	79	57	M	Bladder	Squamous cell carcinoma	*	T3aN0M0	IIIA	Malignant	*
H10	80	46	F	Bladder	Adenocarcinoma	*	T3bN2M0	IIIB	Malignant	*
I1	81	54	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I2	82	78	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I3	83	58	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I4	84	68	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I5	85	73	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I6	86	54	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I7	87	78	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I8	88	58	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I9	89	68	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
I10	90	73	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J1	91	75	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J2	92	65	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J3	93	50	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J4	94	53	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J5	95	53	M	Bladder	Cancer adjacent bladder tissue with squamous metaplasia	*	*	*	AT	*
J6	96	75	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J7	97	65	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J8	98	50	F	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J9	99	53	M	Bladder	Cancer adjacent bladder tissue	*	*	*	AT	*
J10	100	53	M	Bladder	Cancer adjacent bladder tissue with squamous metaplasia	*	*	*	AT	*
_marker_

Find overlapping cases with this tissue array:

UBD1002a

File Format: .xlsx

Release Date: 2025-01-17 16:12:33
Download

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma

	1	2	3	4	5	6	7	8	9	10
A	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
B	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
C	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
D	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
E	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
F	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
G	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
H	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
I	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla
J	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	Bla	_ma